Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daana Pharmaceutical Company is a leading Iranian pharmaceutical manufacturer and one of the largest producers of antibiotics in the Middle East and North Africa (MENA) region. Established in 1998 and headquartered in Tabriz, the company specializes in the production of both Active Pharmaceutical Ingredients (APIs) and finished dosage forms, including soft gelatin capsules, tablets, and sterile injectables. Daana is particularly recognized for its extensive range of penicillin and cephalosporin products, as well as its significant market share in the nutritional supplement sector via softgel technology. The company operates large-scale GMP-compliant facilities and is publicly traded on the Tehran Stock Exchange. It serves as a critical supplier for the domestic market while expanding its export footprint to neighboring countries and the CIS region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daana Pharmaceutical.